BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25872564)

  • 21. New therapeutic options in colon cancer: focus on oxaliplatin.
    Wilkes GM
    Clin J Oncol Nurs; 2002; 6(3):131-7. PubMed ID: 11998605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant hypersensitivity reaction (HSR) presented with persistent dry cough after receiving oxaliplatin in a pancreatic cancer patient.
    Li J; Peccerillo J; Kaley K; Saif MW
    Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):165-8. PubMed ID: 20124609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.
    Baguley DM; Prayuenyong P
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 25. Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy.
    Berretta M; Taibi R; Bearz A; La Mura N; Berretta S; Tirelli U; Frustaci S
    J Chemother; 2004 Dec; 16(6):595-8. PubMed ID: 15700853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.
    Burz C; Berindan-Neagoe IB; Balacescu O; Tanaselia C; Ursu M; Gog A; Vlase L; Chintoanu M; Balacescu L; Leucuta SE; Irimie A; Cristea V
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):39-43. PubMed ID: 19337632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature review.
    Teng CJ; Hsieh YY; Chen KW; Chao TC; Tzeng CH; Wang WS
    Jpn J Clin Oncol; 2011 Jan; 41(1):125-9. PubMed ID: 20826449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of sudden sensorineural hearing loss after methadone overdose.
    Christenson BJ; Marjala AR
    Ann Pharmacother; 2010 Jan; 44(1):207-10. PubMed ID: 20028962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 30. Midventricular Takotsubo cardiomyopathy after oxaliplatin infusion: an unreported side effect.
    Coli S; Pigazzani F; Gaibazzi N
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):646-9. PubMed ID: 25333375
    [No Abstract]   [Full Text] [Related]  

  • 31. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
    Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
    Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunohemolytic anemia following oxaliplatin administration.
    Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
    Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
    [No Abstract]   [Full Text] [Related]  

  • 34. A case report of oxaliplatin extravasation.
    Foo KF; Michael M; Toner G; Zalcberg J
    Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
    [No Abstract]   [Full Text] [Related]  

  • 35. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
    Krexner E; Stickler A; Prainer C; Finsterer J
    Med Oncol; 2012 Dec; 29(5):3592-3. PubMed ID: 22669568
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sudden unilateral sensorineural hearing loss after carbon monoxide intoxication].
    Michalska-Piechowiak T; Miarzyńska M; Perlik-Gattner I
    Przegl Lek; 2004; 61(4):374-6. PubMed ID: 15521607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden sensorineural hearing loss associated with vardenafil.
    Snodgrass AJ; Campbell HM; Mace DL; Faria VL; Swanson KM; Holodniy M
    Pharmacotherapy; 2010 Jan; 30(1):112. PubMed ID: 20030481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.